Nasdaq:US$16.39 (+0.41) | HKEX:HK$25.74 (-0.02) | AIM:£2.43 (+0.04)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 13 Jul 2009

Phase II Crohn’s Disease Trial for HMPL-004 Delivers Encouraging Results

1 items
a090713